Abstract
Healthcare in New Zealand (NZ) is funded predominantly by the central government and is free of cost to the people. The overall prevalence of diabetes mellitus (DM) in NZ is 3.76%, although the prevalence is 6.83% in the Maori and 11.14% in Pacific Island people and significantly lower (2.78%) in people from Europe. Among Maoris with type 1 DM, the crude incidence of renal replacement therapy (dialysis or transplantation) is 11-fold higher than for NZ Europeans with type 1 DM and 41-fold higher than for NZ Europeans with type 2 DM. Life expectancy at age 25 for Maori people with DM is 8.7 years less than for non-Maori people with DM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
